Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Buti Maria; Tsai Naoky; Petersen Joerg; Flisiak Robert; Gurel Selim; Krastev Zahary; Schall Raul Aguilar; Flaherty John F.; Martins Eduardo B.; Charuworn Prista; Kitrinos Kathryn M.; Subramanian G. Mani; Gane Edward; Marcellin Patrick

首页> 外文期刊>Digestive Diseases and Sciences >Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

【24h】

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

机译：替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Long-term tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB) is associated with sustained viral suppression and regression of fibrosis and cirrhosis at year 5 (240 weeks) and no TDF resistance through 6 years (288 weeks).

机译：背景长期对慢性乙型肝炎（CHB）进行替诺福韦酯富马酸二甲氧呋酯（TDF）治疗与病毒的持续抑制以及在第5年（240周）的纤维化和肝硬化消退有关，并且在6年（288周）内无TDF耐药性。

著录项

来源
《Digestive Diseases and Sciences》 |2015年第5期|共8页
作者
Buti Maria; Tsai Naoky; Petersen Joerg; Flisiak Robert; Gurel Selim; Krastev Zahary; Schall Raul Aguilar; Flaherty John F.; Martins Eduardo B.; Charuworn Prista; Kitrinos Kathryn M.; Subramanian G. Mani; Gane Edward; Marcellin Patrick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Antiviral agent; Cirrhosis; Hepatitis B e antigen; Liver disease;

机译：抗病毒药;肝硬化;乙型肝炎e抗原;肝病;

相似文献

外文文献
中文文献
专利

1. Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection [J] . Buti Maria, Tsai Naoky, Petersen Joerg, Digestive Diseases and Sciences . 2015,第5期

机译：替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性
2. Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection [J] . Marcellin Patrick, Wong David K, Sievert William, Liver international : . 2019,第10期

机译：Tenofovir Disoproxil对慢性乙型肝炎病毒感染治疗的十年疗效和安全性
3. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B [J] . Juan Li, Chunhua Hu, Yi Chen, BMC Infectious Diseases . 2021,第1期

机译：Tenofovir Alafenamide的短期和长期安全性和功效，替诺福韦解毒富马酸盐和敌人与乙型肝炎相关的急性对慢性肝功能衰竭的敌意治疗
4. Modeling and simulation for dynamics of tenofovir disoproxil fumarate anti-HBV infection therapy [C] . Xiao Chen, Jianlong Qiu, Weiqi Qin, Chinese Automation Congress . 2017

机译：替诺福韦富马酸替诺福韦抗乙肝病毒感染治疗动力学建模与仿真
5. Viral Vaccine Vectors for the Treatment of Chronic Hepatitis B Virus Infection. [D] . Reynolds, Tracy Dawn. 2015

机译：用于治疗慢性乙型肝炎病毒感染的病毒疫苗载体。
6. Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection [O] . Maria Buti, Naoky Tsai, Joerg Petersen, -1

机译：替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性
7. Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection [O] . 2015

机译：替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

摘要

著录项

相似文献

相关主题

期刊订阅